• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫抑制和达那唑成功治疗端粒病相关间质性肺疾病

Successful treatment of telomeropathy-related interstitial lung disease with immunosuppression and danazol.

作者信息

Chambers Daniel C, Lutzky Viviana P, Apte Simon H, Godbolt David, Feenstra John, Mackintosh John

机构信息

Qld Lung Transplant Service The Prince Charles Hospital Brisbane QLD Australia.

School of Clinical Medicine The University of Queensland Brisbane QLD Australia.

出版信息

Respirol Case Rep. 2020 Jun 25;8(6):e00607. doi: 10.1002/rcr2.607. eCollection 2020 Aug.

DOI:10.1002/rcr2.607
PMID:32607243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7316582/
Abstract

We report the case of a 42-year-old female with a history of finger clubbing which improved during pregnancy, a history of unexplained hepatosplenomegaly, and subsequent non-specific interstitial pneumonia with respiratory failure. Given a personal and family history of early greying of the hair, the peripheral blood monocyte telomere length was measured and was confirmed to be <1st centile, explaining the multiorgan presentation. She was treated with prednisolone, mycophenolate mofetil, and the synthetic androgen danazol with a dramatic improvement in respiratory failure and lung function. After 18 months of danazol treatment, the peripheral blood monocyte telomere length had returned to the normal range.

摘要

我们报告了一例42岁女性病例,该患者有杵状指病史(孕期有所改善)、不明原因肝脾肿大病史,随后出现非特异性间质性肺炎并伴有呼吸衰竭。鉴于其个人及家族有早生白发史,遂检测外周血单核细胞端粒长度,结果证实其低于第1百分位数,这解释了多器官受累的表现。她接受了泼尼松龙、霉酚酸酯和合成雄激素达那唑治疗,呼吸衰竭和肺功能得到显著改善。达那唑治疗18个月后,外周血单核细胞端粒长度恢复至正常范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/7316582/c7a44c94504b/RCR2-8-e00607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/7316582/2156a585a5a2/RCR2-8-e00607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/7316582/c7a44c94504b/RCR2-8-e00607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/7316582/2156a585a5a2/RCR2-8-e00607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a227/7316582/c7a44c94504b/RCR2-8-e00607-g002.jpg

相似文献

1
Successful treatment of telomeropathy-related interstitial lung disease with immunosuppression and danazol.免疫抑制和达那唑成功治疗端粒病相关间质性肺疾病
Respirol Case Rep. 2020 Jun 25;8(6):e00607. doi: 10.1002/rcr2.607. eCollection 2020 Aug.
2
Short Telomere Syndrome presenting with pulmonary fibrosis, liver cirrhosis and hepatopulmonary syndrome: a case report.短端粒综合征伴肺纤维化、肝硬化和肝肺综合征:病例报告。
BMC Pulm Med. 2023 Apr 11;23(1):114. doi: 10.1186/s12890-023-02378-8.
3
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.霉酚酸酯与口服环磷酰胺治疗硬皮病相关间质性肺病(SLS II):一项随机对照、双盲、平行组试验。
Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.
4
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis.TELO-SCOPE 研究:丹那唑治疗短端粒相关肺纤维化的随机、双盲、安慰剂对照 2 期试验。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001127.
5
Telomere biology disorder presenting acutely with pulmonary fibrosis and hepatopulmonary syndrome in a young adult male.一名年轻成年男性急性出现端粒生物学障碍,并伴有肺纤维化和肝肺综合征。
Respirol Case Rep. 2023 Jun 30;11(8):e01182. doi: 10.1002/rcr2.1182. eCollection 2023 Aug.
6
Danazol Treatment for Telomere Diseases.达那唑治疗端粒疾病
N Engl J Med. 2016 May 19;374(20):1922-31. doi: 10.1056/NEJMoa1515319.
7
Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita.雄激素衍生物达那唑、羟甲烯龙和诺龙对先天性角化不良症患者原代造血细胞端粒酶活性的可比影响。
Int J Mol Sci. 2020 Sep 29;21(19):7196. doi: 10.3390/ijms21197196.
8
A 55-year-old craftsman with dyspnea and clubbing: a case report.一名患有呼吸困难和杵状指的55岁工匠:病例报告。
Cases J. 2009 Sep 9;2:8579. doi: 10.4076/1757-1626-2-8579.
9
Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review.先天性角化不良症中的肺纤维化:一例病例报告及 PRISMA 合规性系统评价。
BMC Pulm Med. 2021 Sep 3;21(1):279. doi: 10.1186/s12890-021-01645-w.
10
Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation.活体供体肺叶移植术后成功停用霉酚酸酯的两例病例报告。
Transplant Proc. 2013 Jan-Feb;45(1):356-9. doi: 10.1016/j.transproceed.2012.09.112.

引用本文的文献

1
Pharmacotherapeutic Considerations on Telomere Biology: The Positive Effect of Pharmacologically Active Substances on Telomere Length.药物治疗学对端粒生物学的考虑:药物活性物质对端粒长度的积极影响。
Int J Mol Sci. 2024 Jul 13;25(14):7694. doi: 10.3390/ijms25147694.
2
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.特发性肺纤维化和进行性肺纤维化的治疗:2023 年澳大利亚和新西兰胸科学会立场声明的修订版。
Respirology. 2024 Feb;29(2):105-135. doi: 10.1111/resp.14656. Epub 2024 Jan 11.
3
No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis.

本文引用的文献

1
Telomere length and genetic variant associations with interstitial lung disease progression and survival.端粒长度与基因变异与间质性肺疾病进展和生存的关系。
Eur Respir J. 2019 Apr 11;53(4). doi: 10.1183/13993003.01641-2018. Print 2019 Apr.
2
Danazol Treatment for Telomere Diseases.达那唑治疗端粒疾病
N Engl J Med. 2016 May 19;374(20):1922-31. doi: 10.1056/NEJMoa1515319.
3
Telomere length in interstitial lung diseases.肺间质疾病中的端粒长度。
达那唑治疗对晚期特发性肺纤维化患者无效。
ERJ Open Res. 2023 Sep 25;9(5). doi: 10.1183/23120541.00131-2023. eCollection 2023 Sep.
4
Germline variant of CTC1 gene in a patient with pulmonary fibrosis and myelodysplastic syndrome.一名患有肺纤维化和骨髓增生异常综合征患者的CTC1基因种系变异
Multidiscip Respir Med. 2023 Jun 5;18(1):909. doi: 10.4081/mrm.2023.909. eCollection 2023 Jan 17.
5
Advances in cellular senescence in idiopathic pulmonary fibrosis (Review).特发性肺纤维化中细胞衰老的研究进展(综述)
Exp Ther Med. 2023 Feb 15;25(4):145. doi: 10.3892/etm.2023.11844. eCollection 2023 Apr.
6
Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis.特发性肺纤维化的分子机制、治疗靶点及药物研发研究进展
Front Pharmacol. 2022 Jul 21;13:963054. doi: 10.3389/fphar.2022.963054. eCollection 2022.
7
Telomere Shortening and Its Association with Cell Dysfunction in Lung Diseases.端粒缩短及其与肺部疾病中细胞功能障碍的关系。
Int J Mol Sci. 2021 Dec 31;23(1):425. doi: 10.3390/ijms23010425.
8
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis.TELO-SCOPE 研究:丹那唑治疗短端粒相关肺纤维化的随机、双盲、安慰剂对照 2 期试验。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001127.
9
Telomeres in Interstitial Lung Disease.间质性肺疾病中的端粒
J Clin Med. 2021 Mar 30;10(7):1384. doi: 10.3390/jcm10071384.
Chest. 2015 Oct;148(4):1011-1018. doi: 10.1378/chest.14-3078.
4
Lung fibrosis, premature graying, and macrocytosis.肺纤维化、早老性白发和大红细胞症。
Am J Respir Crit Care Med. 2012 Sep 1;186(5):e8-9. doi: 10.1164/rccm.201112-2175IM.
5
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.作用于TERT基因的性激素可增加人类原代造血细胞中的端粒酶活性。
Blood. 2009 Sep 10;114(11):2236-43. doi: 10.1182/blood-2008-09-178871. Epub 2009 Jun 26.